Exploration of the Pleural Cavity Using a fleXible endoscoPe (EXPLORE)

August 16, 2016 updated by: University Hospital, Rouen

Exploration of the Pleural Cavity Using a fleXible endoscoPe Under Two-Lung ventilatiOn With contRollEd Capnothorax

EXPLORE is a first-in-human study of single port transdiaphragmatic thoracoscopy using a flexible gastro-intestinal endoscope under two-lung ventilation with controlled capnothorax.

Study Overview

Detailed Description

Thoracoscopy is usually performed either with rigid thoracoscopes, or with flexible bronchoscopes. The latter is less invasive and less expensive, but flexible bronchoscopes are difficult to manipulate within the pleural cavity and do not provide an adequate orientation within the pleural space. It is therefore associated with a lower diagnostic yield than thoracoscopy with rigid thoracoscopes. On the other hand, rigid thoracoscopes are associated with more pain, a higher cost, and usually require one-lung ventilation. Gastro-intestinal endoscopes allow a better orientation than bronchoscopes in cavities, and have wider operative channels. The EXPLORE study investigates the feasibility and safety of single port transdiaphragmatic thoracoscopy using a flexible gastro-intestinal endoscope under two-lung ventilation with controlled capnothorax.

Study Type

Interventional

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of pleural effusion affirmed by chest radiography,
  • Indication thoracoscopy, asked by the pulmonologist or thoracic surgeon for diagnostic investigation and / or pleural symphysis
  • Inpatient or outpatient,
  • Women of childbearing age having an effective contraceptive coverage (combined oral contraceptives or intrauterine device or tubal ligation); a negative pregnancy test should be obtained,
  • For postmenopausal women, menopause confirmation of diagnosis,

Exclusion Criteria:

  • Pleural effusion compression,
  • Pleural effusion infected or suspected of infection,
  • Febrile patient (> 38 ° C)
  • Parapneumonic effusion
  • Immunosuppression (eg, neutropenia <1G / L, immunosuppressive therapy, ...)
  • Portage known multidrug-resistant germ or S. aureus resistant to methicillin,
  • Clinical suspicion of tuberculosis,
  • Patients who have already been treated by pleurodesis,
  • Contraindication to general anesthesia,
  • Contraindication of prophylactic antibiotics,
  • Contraindication to pleurodesis agent
  • Increased bleeding risk,
  • No one deprived of liberty by an administrative or judicial decision or protected adult subject (under guardianship)
  • Pregnant or breastfeeding women.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Thoracoscopy
  1. experimental intervention (flexible video endoscope)
  2. reference procedure (video-rigid thoracoscope)
Thoracoscopy is done using flexible video endoscope
Thoracoscopy is done using video-rigid thoracoscope

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Completeness of the pleural cavity exploration using the flexible endoscope
Time Frame: at 0 hours
Two independent experts will visualize the video-recordings of the intervention and evaluate the completeness of the exploration using a standardized score.
at 0 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Outcome of a complication
Time Frame: at 0 hours
Complications are defined by any of the following: any grade >2 event of the Clavien-Dindo classification, a documented or suspected infection, a non programmed admission to the hospital, a prolongation of hospitalization, or death.
at 0 hours
Outcome of a complication
Time Frame: at 4 hours
Complications are defined by any of the following: any grade >2 event of the Clavien-Dindo classification, a documented or suspected infection, a non programmed admission to the hospital, a prolongation of hospitalization, or death.
at 4 hours
Outcome of a complication
Time Frame: Day 7
Complications are defined by any of the following: any grade >2 event of the Clavien-Dindo classification, a documented or suspected infection, a non programmed admission to the hospital, a prolongation of hospitalization, or death.
Day 7
Outcome of a complication
Time Frame: 1 month
Complications are defined by any of the following: any grade >2 event of the Clavien-Dindo classification, a documented or suspected infection, a non programmed admission to the hospital, a prolongation of hospitalization, or death.
1 month
Results of the microbiological analysis of samples collected on the endoscope seven days before the intervention
Time Frame: Day -7 : 7 days before the intervention
Day -7 : 7 days before the intervention
Results of the microbiological analysis of samples collected on the endoscope the day of the intervention
Time Frame: at 0 hours
at 0 hours
Completeness of the pleural cavity exploration using the standard three-ports thoracoscopy with one-lung ventilation
Time Frame: at 0 hours
Two independent experts will visualize the video-recordings of the intervention and evaluate tee completeness of the exploration using a standardized score.
at 0 hours
Diagnostic yield of biopsies performed with the flexible endoscope
Time Frame: Day 1
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: BASTE Jean Marc, MD, Rouen University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2016

Primary Completion (Actual)

June 1, 2016

Study Completion (Actual)

July 1, 2016

Study Registration Dates

First Submitted

April 30, 2015

First Submitted That Met QC Criteria

June 3, 2015

First Posted (Estimate)

June 4, 2015

Study Record Updates

Last Update Posted (Estimate)

August 17, 2016

Last Update Submitted That Met QC Criteria

August 16, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 2014/182/HP
  • 2014-A01660-47 (Other Identifier: ANSM)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pleural Effusion

Clinical Trials on flexible video endoscope

3
Subscribe